Guadalupe T. Mateo-Gonzalez

Guadalajara, CM, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions.

Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: April 25, 2025

STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis.

STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis.

Journal: The Journal of pathology
Published: January 31, 2025

Biomarker and clinical data-based predictor tool (MAUXI) for ultrafiltration failure and cardiovascular outcome in peritoneal dialysis patients: a retrospective and longitudinal study.

Biomarker and clinical data-based predictor tool (MAUXI) for ultrafiltration failure and cardiovascular outcome in peritoneal dialysis patients: a retrospective and longitudinal study.

Journal: BMJ health & care informatics
Published: May 21, 2024

Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection.

Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection.

Journal: Frontiers in cellular and infection microbiology
Published: August 29, 2023

Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis.

Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis.

Journal: International journal of molecular sciences
Published: January 31, 2023

Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis.

Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis.

Journal: The Journal of pathology
Published: December 22, 2022

Potential Therapeutic Effects of Natural Plant Compounds in Kidney Disease.

Potential Therapeutic Effects of Natural Plant Compounds in Kidney Disease.

Journal: Molecules (Basel, Switzerland)
Published: September 08, 2021

Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid.

Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid.

Journal: Biomolecules
Published: July 16, 2020

Lithium preserves peritoneal membrane integrity by suppressing mesothelial cell αB-crystallin.

Lithium preserves peritoneal membrane integrity by suppressing mesothelial cell αB-crystallin.

Journal: Science translational medicine
Published: October 25, 2019

Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition.

Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition.

Journal: Frontiers in pharmacology
Published: March 10, 2019

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis.

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis.

Journal: Journal of visualized experiments : JoVE
Published: August 07, 2018

Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.

Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.

Journal: Kidney international
Published: October 20, 2017
Showing 1-12 of 25

Last Updated: 09/26/2026